Physicians from The Johns Hopkins Scleroderma Center work closely with colleagues from around the nation.
The Johns Hopkins Scleroderma Center works collaboratively with faculty from the Johns Hopkins Division of Rheumatology, other members of Johns Hopkins University, and investigators and clinicians from other institutions:
- Maureen Mayes, M.D., M.P.H., Professor of Medicine, University of Texas Health Science Center at Houston
- Jennifer van Eyk, Ph.D., Cedars-Sinai Medical Center
- John Varga, M.D., Gallagher Research Professor in Rheumatology, Northwestern University Feinberg School of Medicine
- Monique Hinchcliff, M.D., Northwestern University Feinberg School of Medicine
- Virginia D. Steen, M.D., Professor of Medicine, Georgetown University Medical Center
- Christopher Denton, Ph.D., FRCP, Professor of Experimental Rheumatology, Royal Free Hospital, London
- Dr. Voon Ong, Senior Lecturer, Royal Free Hospital, London
- Ms. Korsa Khan, Laboratory Manager, Royal Free Hospital, London
- Dinesh Khanna, M.D., MS, Associate Professor of Internal Medicine, University of Michigan
- Tracy Frech, M.D., MS, University of Utah
- Brett Thombs, Ph.D., Assistant Professor, Department of Psychiatry, McGill University, Canada
- Marie Hudson, M.D., Assistant Professor of Medicine, McGill University, Canada
- Lorinda Chung, M.D., Assistant Professor of Rheumatology, Stanford University
- Shikha Mittoo, M.D., MHS, Assistant Professor, University of Toronto
- Lesley Ann Saketkoo, M.D., MPH, Louisiana State University
- Robyn Domsic, M.D., University of Pittsburgh
- Kathleen Barnes, Ph.D., University of Colorado School of Medicine
In addition, Johns Hopkins Scleroderma Center physicians and staff collaborate with private industry to develop novel treatments and new tools for studying scleroderma:
- CSL Behring
- Corbus Pharmaceutics
- Boehringer-Ingelheim
- Cytori Therapeutics
- Allergen, Inc.
